Aquestive Therapeutics (AQST) Current Deferred Revenue (2018 - 2026)
Aquestive Therapeutics (AQST) reported Current Deferred Revenue of $1.09 million for Q3 2026, unchanged from $1.09 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aquestive Therapeutics (AQST) Current Deferred Revenue (2018 - 2026) Analysis & Trends
Dating back to Q4 2018, Aquestive Therapeutics' Current Deferred Revenue record includes 32 quarters.
- Current Deferred Revenue has a five-year compound annual growth rate of 9.5% (FY2020 to FY2025).
- By year, Current Deferred Revenue came in at $1.05 million in FY2024 (-32.4%), $1.55 million in FY2023 (+2.5%), $1.51 million in FY2022 (+97.8%) and $765,000 in FY2021 (+10.4%).
- Five-year quarterly Current Deferred Revenue spans a low of $765,000 in Q4 2021 and a high of $4.77 million in Q1 2023.
- Year over year, Current Deferred Revenue gained in four of the last eight quarters, with an average decline of 6.0%.
- The high point for year-over-year Current Deferred Revenue in five years was Q1 2022 (growth of 265.9%); the low point was Q2 2024 (a decline of 73.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.09 million (Q2 2026), $1.09 million (Q1 2026) and $1.09 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Aquestive Therapeutics | 445.70 Mn | 24.96 Mn | 3.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.09 Mn |
| Jun 30, 2026 | 1.09 Mn |
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.55 Mn |
| Dec 31, 2023 | 1.55 Mn |
| Sep 30, 2023 | 2.64 Mn |
| Jun 30, 2023 | 3.99 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 1.51 Mn |
| Sep 30, 2022 | 774,000.00 |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | 765,000.00 |
API Access
Aquestive Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AQST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "AQST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=AQST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();